One Rep Global is the India Partner for My Private Villas Representing Them in the Outbound Tourism Sector of the Indian Market
One Rep Global announces its appointment as the India partner for My Private Villas to…
5 years ago
XPeng Announces Closing of Follow-On Public Offering and Full Exercise of the Underwriters’ Overallotment Option
GUANGZHOU, China--(BUSINESS WIRE)--$XPEV #EV--XPeng Inc. (“XPeng” or the “Company”, NYSE:XPEV), a leading Chinese smart electric…
5 years ago
QIAGEN N.V. Announces Conversion Price of New Net Share Settled Convertible Bonds and Price to Non-US Holders to Sell Outstanding Convertible Notes Due 2021
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION INTO OR IN THE UNITED STATES, AUSTRALIA, JAPAN, SOUTH…
5 years ago
PROTEOR Group Becomes One of the Largest Prosthetic Providers in the World
With FTC Approval, Proteor Completes Strategic Acquisition of Freedom Innovations Assets TEMPE, Ariz. & DIJON,…
5 years ago
Galton Voysey Donates 30,000 Meals to Fight Against Hunger and COVID-19
HONG KONG--(BUSINESS WIRE)--#galtonvoysey--Galton Voysey, its fully owned brands and customers have joined together to donate…
5 years ago
Complimentary Ticket to Join YAFO ACCESS CHINA Forum 2021
SHANGHAI--(BUSINESS WIRE)--YAFO Life Science and BioToChina.org announced the schedule for ACCESS CHINA Forum 2021 (January…
5 years ago
Eros Now Announces its Biggest Content Slate, Underpinning Growth in the OTT Sector
Adding 46 titles in 2021, including 13 original series and 33 film premieres across 8…
5 years ago
Inseego 5G MiFi® M2000 Now Available in Japan, Significantly Expanding Presence in the Region
Secures first 5G award in Japan with Sumitomo Corporation subsidiary, Grape One Ltd.; mobile hotspot…
5 years ago
WNS Extends Partnership with Scandinavian Airlines
NEW YORK & LONDON & MUMBAI, India--(BUSINESS WIRE)--#BPM--WNS (Holdings) Limited (NYSE: WNS), a leading provider…
5 years ago
Trastuzumab Deruxtecan Recommended for Approval in the EU by CHMP for HER2 Positive Metastatic Breast Cancer
Recommendation based on positive results from the DESTINY-Breast01 trial, which showed durable responses in patients…
5 years ago